Trademark: 87863481
Status Date
Monday, March 28, 2022
Filing Date
Wednesday, April 4, 2018
Published for Opposition
Tuesday, December 25, 2018
Abandoned Date
Monday, March 28, 2022
9 Computer software for scientific and medical analysis of genetic sequences; computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics; computer software for receiving, processing, transmitting and displaying data for use in genetic analysis
5 Medical diagnostic reagents; clinical diagnostic reagents for medical use; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing; medical diagnostic assays for medical and diagnostic purposes; medical diagnostic reagents and assays for testing body fluids; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes
1 Kits comprising primarily of regents, enzymes and nucleotides for genetic research, forensic research, non-medical human identification, medical and scientific research; reagents, enzymes, and nucleotides for scientific or medical research use; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or medical research purposes; reagents for scientific or medical research use, namely, reagents for use in preparation of DNA sequencing samples
44 Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes; providing medical genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases; providing a website featuring medically relevant information regarding genetics for educational purposes
42 Nucleic acid sequencing and analysis services for scientific and research purposes; genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; genome sequencing and analysis services for forensic purposes; genome sequencing and analysis services for genotoxicity purposes; structural and functional analysis of genomes; medical and scientific research in the field of cancer detection, diagnosis and monitoring; providing medical and scientific information in the fields of pharmaceuticals and genetics; pharmaceutical research and development services; providing temporary use of non-downloadable computer software for scientific and medical analysis of genetic sequences; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics
DUP SEQ
DUPLEX SEQUENCING
Mar 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 28, 2022
Abandonment - No Use Statement Filed
Nov 3, 2021
Assigned To Examiner
Aug 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2021
Sou Extension 5 Granted
Aug 10, 2021
Sou Extension 5 Filed
Aug 16, 2021
Case Assigned To Intent To Use Paralegal
Aug 10, 2021
Sou Teas Extension Received
Feb 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 18, 2021
Sou Extension 4 Granted
Feb 18, 2021
Sou Extension 4 Filed
Feb 18, 2021
Sou Teas Extension Received
Aug 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 19, 2020
Sou Extension 3 Granted
Aug 19, 2020
Sou Extension 3 Filed
Aug 19, 2020
Sou Teas Extension Received
Jun 3, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 3, 2020
Teas Change Of Correspondence Received
Jun 3, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 3, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 3, 2020
Teas Change Of Owner Address Received
Feb 12, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2020
Sou Extension 2 Granted
Feb 10, 2020
Sou Extension 2 Filed
Feb 10, 2020
Sou Teas Extension Received
Aug 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2019
Sou Extension 1 Granted
Aug 2, 2019
Sou Extension 1 Filed
Aug 2, 2019
Sou Teas Extension Received
Feb 19, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 25, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 25, 2018
Published For Opposition
Dec 5, 2018
Notification Of Notice Of Publication E-Mailed
Nov 13, 2018
Approved For Pub - Principal Register
Nov 13, 2018
Examiner's Amendment Entered
Nov 13, 2018
Notification Of Examiners Amendment E-Mailed
Nov 13, 2018
Examiners Amendment E-Mailed
Nov 13, 2018
Examiners Amendment -Written
Nov 9, 2018
Previous Allowance Count Withdrawn
Nov 6, 2018
Withdrawn From Pub - Og Review Query
Oct 19, 2018
Law Office Publication Review Completed
Oct 19, 2018
Assigned To Lie
Oct 4, 2018
Approved For Pub - Principal Register
Oct 2, 2018
Examiner's Amendment Entered
Oct 2, 2018
Notification Of Examiners Amendment E-Mailed
Oct 2, 2018
Examiners Amendment E-Mailed
Oct 2, 2018
Examiners Amendment -Written
Aug 1, 2018
Notification Of Non-Final Action E-Mailed
Aug 1, 2018
Non-Final Action E-Mailed
Aug 1, 2018
Non-Final Action Written
Jul 21, 2018
Assigned To Examiner
Apr 13, 2018
New Application Office Supplied Data Entered
Apr 7, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
